Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine (Telemalrares)

Toulouse University Hospital

Status: Completed

Conditions: Skin Disease

Treatments: Procedure: telemedicine

Study type: Interventional

Funder types: Other

Identifiers

NCT02465476

RC31/13/6901

Details and patient eligibility

About

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Enrollment: 212 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre
• Or patients already take-over by the centre but lost to follow-up for more than one year
• Patients (and/or parents) who give their consents
• Patients (and/or parents) able to fill in questionnaires

Exclusion criteria

• Pregnant or breast-feeding women.
• Patients subject to a judicial safeguard order
• Patients who need an emergency take-over
• Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

212 participants in 2 patient groups

normal care

No Intervention group

Description:

patient who will have normal treatment pathway

telemedicine

Experimental group

Description:

patient who will have telemedicine

Treatment:

Procedure: telemedicine